Asean Health Screening Market
حجم السوق بالمليار دولار أمريكي
CAGR :
% 
 فترة التنبؤ |
2024 –2031 |
 حجم السوق (السنة الأساسية) |
USD 17,697.22 Million |
 حجم السوق (سنة التنبؤ) |
USD 47,078.82 Million |
 CAGR |
% |
| Major Markets Players |
سوق الفحص الصحي في رابطة دول جنوب شرق آسيا ، حسب نوع الاختبار (اختبارات الكوليسترول، اختبار السكري، اختبارات السرطان، اختبار الفحص العام، الأمراض المنقولة جنسياً، اختبار ضغط الدم، وغيرها)، التطبيق (أمراض القلب والأوعية الدموية، الاضطرابات الأيضية، الأورام، الحالات الالتهابية، اضطرابات الجهاز العضلي الهيكلي، الحالات العصبية، مضاعفات التهاب الكبد الوبائي سي، الحالات المرتبطة بالمناعة، وغيرها)، نوع اللوحة (لوحات متعددة الاختبارات، لوحات اختبار واحدة)، الرعاية / المرفق (متكامل، مستقل)، المستخدم (المستخدم المحلي، السياحة الطبية)، دخل العميل (الطبقة العليا، الطبقة المتوسطة، والطبقة الدنيا)، المزود (المستشفيات والعيادات ومرافق التمريض ومراكز إعادة التأهيل والمختبرات التشخيصية وغيرها)، الدول (الهند وسنغافورة وتايلاند وماليزيا وإندونيسيا والفلبين وفيتنام وكمبوديا وبروناي وبورما ولاوس) - اتجاهات الصناعة والتوقعات 2031.
تحليل ورؤى حول سوق الفحص الصحي في رابطة دول جنوب شرق آسيا
في أكتوبر 2023، وفقًا للحدث المسمى "اليوم الدولي لكبار السن في آسيا والمحيط الهادئ، 2023" المنشور على موقع اللجنة الاقتصادية والاجتماعية لآسيا والمحيط الهادئ. في عام 2023، يقدر عدد كبار السن (60 عامًا أو أكثر) المقيمين في آسيا والمحيط الهادئ بنحو 697 مليون شخص، وهو ما يمثل حوالي 60 في المائة من جميع كبار السن في العالم. يبلغ عمر حوالي واحد من كل 7 أشخاص في المنطقة حاليًا 60 عامًا أو أكثر، وبحلول عام 2050، سيكون هناك واحد من كل 4 أشخاص ينتمون إلى هذه الفئة العمرية. تمثل النساء حوالي 54 في المائة من جميع النساء المسنات. ومع تقدم العمر، تزداد حصتهن. وبالتالي، تشكل النساء معظم كبار السن في المنطقة. إن شيخوخة السكان في آسيا والمحيط الهادئ سريعة بشكل خاص، نظرًا لانخفاض الخصوبة والوفيات على مدى السنوات الأخيرة. وهذا يترجم إلى وقت محدود للاستعداد لتأثيرات الشيخوخة على المجتمعات.
تحلل شركة Data Bridge Market Research أن سوق الفحص الصحي في رابطة دول جنوب شرق آسيا من المتوقع أن يصل إلى 47،078.82 مليون دولار أمريكي بحلول عام 2031 من 17،697.22 مليون دولار أمريكي في عام 2023، بمعدل نمو سنوي مركب قدره 13.5٪ في الفترة المتوقعة من 2024 إلى 2031.
|
تقرير القياس |
تفاصيل |
|
فترة التنبؤ |
2024 إلى 2031 |
|
سنة الأساس |
2023 |
|
سنوات تاريخية |
2022 (قابلة للتخصيص للفترة 2016-2021) |
|
وحدات كمية |
الإيرادات بالملايين من الدولارات الأمريكية |
|
القطاعات المغطاة |
نوع الاختبار (اختبارات الكوليسترول، اختبار السكري ، اختبارات السرطان، اختبار الفحص العام، الأمراض المنقولة جنسياً، اختبار ضغط الدم، وغيرها)، التطبيق ( أمراض القلب والأوعية الدموية ، الاضطرابات الأيضية، الأورام، الحالات الالتهابية، اضطرابات الجهاز العضلي الهيكلي، الحالات العصبية، مضاعفات التهاب الكبد الوبائي سي، الحالات المتعلقة بالمناعة، وغيرها)، نوع اللوحة (لوحات متعددة الاختبارات، لوحات اختبار واحدة)، الرعاية/المنشأة (متكاملة، مستقلة)، المستخدم (المستخدم المحلي، السائح الطبي)، دخل العميل (الطبقة العليا، الطبقة المتوسطة، والطبقة الدنيا)، المزود (المستشفيات والعيادات ومرافق التمريض ومراكز إعادة التأهيل والمختبرات التشخيصية وغيرها)، الدول (الهند وسنغافورة وتايلاند وماليزيا وإندونيسيا والفلبين وفيتنام وكمبوديا وبروناي وبورما ولاوس) |
|
الدول المغطاة |
الهند وسنغافورة وتايلاند وماليزيا وإندونيسيا والفلبين وفيتنام وكمبوديا وبروناي وبورما ولاوس |
|
الجهات الفاعلة في السوق المشمولة |
شركة فوليرتون هيلث كوربوريشن المحدودة، ومستشفى ماونت ألفرنيا، وشركة بي تي بروديا ويدياهوسادا تي بي كيه، ومجموعة رافلز الطبية، ومجموعة آيكون، وغيرها |
تعريف السوق
يعد الفحص الصحي أداة مهمة للكشف المبكر عن الأمراض. وكثيراً ما تستخدم اختبارات الفحص في الطب الوقائي لتحديد ما إذا كان الشخص يعاني من مؤشرات مبكرة لعوامل الخطر المرتبطة بحالة صحية معينة. ومن بين الأمراض التي يمكن اكتشافها عن طريق الفحص السرطان والسكري وارتفاع نسبة الكوليسترول وارتفاع ضغط الدم وهشاشة العظام.
يشتمل هذا السوق على مجموعة واسعة من الأنشطة، بما في ذلك الفحوصات الصحية الروتينية، والفحوصات المتخصصة للأمراض المزمنة مثل مرض السكري والسرطان وأمراض القلب والأوعية الدموية، فضلاً عن إجراءات التشخيص المتقدمة. كما يتضمن استخدام التكنولوجيا والمعدات الطبية لإجراء هذه الاختبارات، وغالبًا ما يشمل برامج إدارة الصحة التي تهدف إلى تعزيز العافية العامة والتدخل المبكر. ويعتمد سوق الفحص الصحي على زيادة الوعي العام بالرعاية الوقائية، والتقدم في تكنولوجيا التشخيص، والطلب المتزايد على حلول الرعاية الصحية الشخصية.
ديناميكيات سوق الفحص الصحي في رابطة دول جنوب شرق آسيا
يتناول هذا القسم فهم محركات السوق والفرص والقيود والتحديات. وسيتم مناقشة كل هذا بالتفصيل أدناه:
سائق
- زيادة عدد السكان المسنين
إن الزيادة في عدد السكان المسنين في منطقة الآسيان هي المحرك الرئيسي لسوق الفحص الصحي. على سبيل المثال، في عام 2020، كان 13.6 في المائة من السكان في آسيا والمحيط الهادئ يبلغون من العمر 60 عامًا أو أكثر، وبحلول عام 2050 سيكونون ربع السكان. يلعب الفحص الصحي دورًا حاسمًا في هذا السياق من خلال تقديم الفحوصات الروتينية والاختبارات التشخيصية والفحوصات لمختلف الحالات الصحية مثل أمراض القلب والأوعية الدموية والسرطان والسكري واضطرابات الجهاز التنفسي.
While longer lifespans reflect the region’s development success, comprehensive policy reforms are urgently needed to support the welfare of older people, according to Aging Well in Asia: Asian Development Policy Report, released by the Asian Development Bank (ADB) at its 57th Annual Meeting. The number of people aged 60 and older in developing Asia and the Pacific is set to nearly double by 2050 to 1.2 billion—or about a quarter of the total population—significantly increasing the need for pension and welfare programs as well as health care services.
The demand for health screening services is further bolstered by increasing healthcare expenditures, rising disposable incomes, and a growing understanding of the benefits of proactive healthcare management among the aging population in ASEAN. As a result, the health screening market in the region is expected to continue expanding to meet the needs of the increasing geriatric demographic.
Restraint
- High Cost of Healthcare Services
The high cost of health screening services presents a significant restraint for the ASEAN health screening market. Affordability remains a key concern, particularly in low- and middle-income countries where a large portion of the population struggle to access or afford comprehensive health screenings. This economic barrier limits the widespread adoption of preventive healthcare measures and early detection services, hindering efforts to combat the rising burden of chronic diseases in the region. Addressing the issue of high costs requires collaborative efforts from governments, healthcare providers, and private sector entities to develop cost-effective screening solutions, negotiate affordable pricing structures, and implement subsidies or insurance schemes to enhance accessibility for underserved populations.
Opportunity
- Technological Advancements in Health Screening
Innovations in imaging technology, molecular diagnostics, and digital health solutions have revolutionized how diseases are detected and monitored. Technologies such as PCR-based assays, high-resolution imaging techniques, and artificial intelligence-driven analytics have improved the accuracy, speed, and accessibility of health screening tests. This not only benefits healthcare providers by enabling earlier and more precise diagnoses but also empowers patients with better understanding and management of their health.
Moreover, the introduction of these advanced technologies has created a competitive environment where companies strive to differentiate themselves through innovation. These dynamic drives continuous improvement and the development of increasingly sophisticated screening tools, ultimately expanding the overall market for health screening products and services.
Challenge
- Inadequate Quality Assurance and Control
Variations in equipment calibration, maintenance, and operator training can lead to discrepancies in diagnostic accuracy and reliability. Inconsistent calibration schedules or lack of access to calibration services can result in inaccurate readings, affecting diagnosis and treatment outcomes. Additionally, inadequate maintenance due to budget constraints or lack of skilled technicians can cause equipment malfunctions, leading to downtime and unreliable diagnostic results. The proficiency of healthcare providers in operating diagnostic equipment and conducting screening procedures varies widely, and insufficient training along with the lack of standardized protocols can lead to human errors, further compromising the quality and reliability of screenings.
Recent Developments
- In August 2022, Fullerton Health completed merger led by RRJ Capital; Stronger Balance Sheet and New Corporate Structure propelled the post-pandemic growth opportunities. Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced that it had completed a merger led by RRJ Capital (“RRJ”) involving an equity injection by the private equity firm and a senior loan totalling USD 390 million. The merger delivered a stronger balance sheet and a new capital structure which propelled the post-pandemic growth opportunities for the pan-Asian healthcare provider
ASEAN Health Screening Market Scope
ASEAN health screening market is segmented into eight notable segments based on test type, application, panel type, care/facility, user, customer income, provider, country. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Test Type
- Cholesterol Tests
- Diabetes Test
- Cancer Tests
- General Check Up Test
- STD's
- Blood Pressure Test
- Others
On the basis of test type, the market is segmented into cholesterol tests, diabetes test, cancer tests, general check up test, STD's, blood pressure test, and others.
Application
- Cardiovascular Disease
- Metabolic Disorders
- Oncology
- Inflammatory Conditions
- Musculoskeletal Disorders
- Neurological Conditions
- Hepatitis-C Complications
- Immunology-Related Conditions
- Others
On the basis of application, the market is segmented into cardiovascular disease, metabolic disorders, oncology, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-c complications, immunology-related conditions, and others.
Panel Type
- Multi-Test Panels
- Single-Test Panels
On the basis of panel type, the market is segmented into multi-test panels and single-test panels.
Care/Facility
- Integrated
- Standalone
On the basis of care/facility, the market is segmented into integrated and standalone.
User
- Domestic User
- Medical Tourist
On the basis of user, the market is segmented into domestic user and medical tourist.
Customer Income
- Upper Class
- Medium Class
- Lower Class
على أساس دخل العملاء، يتم تقسيم السوق إلى الطبقة العليا، والطبقة المتوسطة، والطبقة الدنيا.
مزود
- المستشفيات
- العيادات
- مرافق التمريض
- مراكز إعادة التأهيل
- المختبرات التشخيصية
- آحرون
على أساس المزود، يتم تقسيم السوق إلى المستشفيات والعيادات ومرافق التمريض ومراكز إعادة التأهيل والمختبرات التشخيصية وغيرها.
تحليل/رؤى إقليمية لسوق الفحص الصحي في رابطة دول جنوب شرق آسيا
يتم تقسيم سوق الفحص الصحي في رابطة دول جنوب شرق آسيا إلى ثمانية قطاعات بارزة بناءً على نوع الاختبار والتطبيق ونوع اللوحة والرعاية / المنشأة والمستخدم ودخل العميل والمزود والبلد.
الدول التي يغطيها تقرير السوق هذا هي الهند وسنغافورة وتايلاند وماليزيا وإندونيسيا والفلبين وفيتنام وكمبوديا وبروناي وبورما ولاوس.
كما يوفر قسم الدولة في التقرير عوامل فردية مؤثرة على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. تعد نقاط البيانات مثل المبيعات الجديدة ومبيعات الاستبدال والتركيبة السكانية للدولة والقوانين التنظيمية ورسوم الاستيراد والتصدير من بين المؤشرات الرئيسية المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود العلامات التجارية العالمية وتوافرها والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية وتأثير قنوات المبيعات أثناء تقديم تحليل تنبؤي لبيانات الدولة.
تحليل المنافسة وحصة سوق الفحص الصحي في رابطة دول جنوب شرق آسيا
يوفر المشهد التنافسي لسوق الفحص الصحي في رابطة دول جنوب شرق آسيا تفاصيل عن المنافسين. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، ومواقع الإنتاج والمرافق، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وموافقات المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق، ومنحنى خط حياة نوع المنتج. تتعلق نقاط البيانات المذكورة أعلاه فقط بتركيز الشركة على السوق.
بعض اللاعبين الرئيسيين في السوق الذين يعملون في السوق هم Fullerton Health Corporation Limited، وMount Alvernia Hospital، وPt Prodia Widyahusada Tbk.، وRaffles Medical Group، وIcon Group، وشركة The Farrer Park وغيرها.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASEAN HEALTH SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 ASEAN HEALTH SCREENING MARKET: REGULATIONS
5.1 REGULATIONS IN INDIA:
5.2 REGULATIONS IN SINGAPORE:
5.3 REGULATIONS IN THAILAND:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING GERIATRIC POPULATION
6.1.2 RISING NUMBER OF CHRONIC DISEASES
6.1.3 RISING AWARENESS AMONG PEOPLE FOR HEALTH SCREENING
6.2 RESTRAINTS
6.2.1 HIGH COST OF HEALTHCARE SERVICES
6.2.2 LACK OF TRAINED HEALTHCARE PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEALTH SCREENING
6.3.2 ACQUISITIONS AND MERGERS AMONG THE MARKET
6.3.3 NEW PRODUCT AND SERVICE LAUNCHES IN THE MARKET
6.4 CHALLENGES
6.4.1 INADEQUATE QUALITY ASSURANCE AND CONTROL
6.4.2 OPERATIONAL BARRIERS IN CONDUCTING SCREENING TESTS
7 ASEAN HEALTH SCREENING MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 CHOLESTEROL TESTS
7.2.1 TOTAL CHOLESTEROL TEST
7.2.2 TRIGLYCERIDES
7.2.3 LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
7.2.4 HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL
7.3 DIABETES TEST
7.3.1 FASTING/RANDOM BLOOD SUGAR TEST
7.3.2 A1C TEST
7.3.3 GLUCOSE TOLERANCE TEST
7.4 CANCER TESTS
7.4.1 LIQUID BIOPSY
7.4.2 MAMMOGRAMS, OSTEOPOROSIS, BREAST MRI, AND PAP SMEAR TESTS
7.4.3 LOW-DOSE HELICAL COMPUTED TOMOGRAPHY
7.4.4 COLORECTAL CANCER SCREENING TEST (STOOL TESTS, SIGMOIDOSCOPY, COLONOSCOPY, BLOOD-BASED DNA TEST, DOUBLE-CONTRAST BARIUM ENEMA (DCBE), AND SINGLE-SPECIMEN GFOBT)
7.4.5 PROSTATE SPECIFIC ANTIGEN (PSA) TEST
7.4.6 NEW-EARLY DETECTION CANCER TESTS
7.4.7 ALPHA FETOPROTEIN BLOOD TEST
7.4.8 CA-125 TEST
7.4.9 OTHERS
7.5 GENERAL CHECK UP TEST
7.5.1 REGULAR CHECK UP
7.5.1.1 REGULAR BLOOD TEST
7.5.1.2 X-RAYS
7.5.1.3 ECG
7.5.1.4 FECALYSIS
7.5.1.5 URINALYSIS
7.5.1.6 BMI
7.5.1.7 OTHERS
7.5.2 EYE CHECK UP
7.5.3 DENTAL TEST
7.5.4 HEARING TEST
7.6 STD'S
7.6.1 CHLAMYDIA
7.6.2 GONORRHEA
7.6.3 HPV
7.6.4 HIV
7.6.5 OTHERS
7.7 BLOOD PRESSURE TEST
7.8 OTHERS
7.8.1 LIVER FUNCTION TESTS
7.8.2 KIDNEY PROFILE
8 ASEAN HEALTH SCREENING MARKET, BY PANEL TYPE
8.1 OVERVIEW
8.2 MULTI-TEST PANELS
8.3 SINGLE-TEST PANELS
9 ASEAN HEALTH SCREENING MARKET, BY CARE/FACILITY
9.1 OVERVIEW
9.2 INTEGRATED
9.3 STANDALONE
10 ASEAN HEALTH SCREENING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 CARDIOVASCULAR DISEASE
10.2.1 CORONARY HEART DISEASE
10.2.2 ATHEROSCLEROSIS
10.3 METABOLIC DISORDERS
10.3.1 DIABETES MELLITUS
10.3.2 OBESITY
10.4 ONCOLOGY
10.5 INFLAMMATORY CONDITIONS
10.5.1 AUTOIMMUNE CONDITIONS
10.5.2 ALLERGIES
10.5.3 ARTHRITIS
10.5.4 ASTHMA
10.5.5 INFLAMMATORY DIGESTIVE PROBLEMS
10.6 MUSCULOSKELETAL DISORDERS
10.6.1 OSTEOPOROSIS
10.6.2 RHEUMATOID ARTHRITIS
10.7 NEUROLOGICAL CONDITIONS
10.7.1 CHRONIC STRESS
10.7.2 ALZHEIMER'S DISEASE
11 ASEAN HEALTH SCREENING MARKET, BY CUSTOMER INCOME
11.1 OVERVIEW
11.2 UPPER CLASS
11.3 MEDIUM CLASS
11.4 LOWER CLASS
12 ASEAN HEALTH SCREENING MARKET, BY PROVIDER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 NURSING FACILITIES
12.5 REHABILITATION CENTERS
12.6 DIAGNOSTIC LABORATORIES
12.7 OTHERS
13 ASEAN HEALTH SCREENING MARKET, BY USER
13.1 OVERVIEW
13.2 DOMESTIC USER
13.3 MEDICAL TOURIST
14 ASEAN HEALTH SCREENING MARKET, BY COUNTRY
14.1 INDIA
14.2 SINGAPORE
14.3 THAILAND
14.4 MALAYSIA
14.5 INDONESIA
14.6 PHILIPPINES
14.7 VIETNAM
14.8 CAMBODIA
14.9 BRUNEI
14.1 BURMA
14.11 LAOS
15 ASEAN MEDICAL SCREENING MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
16 SWOT ANALYSIS
17 COMPANY PROFILES
17.1 FULLERTON HEALTH CORPORATION LIMITED.
17.1.1 COMPANY SNAPSHOT
17.1.2 PRODUCT PORTFOLIO
17.1.3 RECENT DEVELOPMENT
17.2 MOUNT ALVERNIA HOSPITAL.
17.2.1 COMPANY SNAPSHOT
17.2.2 PRODUCT PORTFOLIO
17.2.3 RECENT DEVELOPMENT
17.3 PT PRODIA WIDYAHUSADA TBK.
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 RAFFLES MEDICAL GROUP
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 ICON GROUP
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.6 THE FARRER PARK COMPANY
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 PT SILOAM INTERNATIONAL HOSPITALS TBK.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 SINGHEALTH GROUP
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 IHH HEALTHCARE BERHAD
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 LIFESCAN MEDICAL & WELLNESS (A SUBSIDIARY OF SINGAPORE MEDICAL GROUP LIMITED)
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 MANADR PTE LTD.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 NATIONAL UNIVERSITY HEALTH SYSTEM.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 PT MEDIKA LOKA MANAJEMEN
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 ROYAL HEALTHCARE
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 ROYAL PHNOM PENH HOSPITAL
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 KALBE
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 ASEAN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 2 ASEAN CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 3 ASEAN DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 4 ASEAN CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 5 ASEAN GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 6 ASEAN REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 7 ASEAN STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 8 ASEAN OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 9 ASEAN HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 10 ASEAN HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)..
TABLE 11 ASEAN HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 12 ASEAN CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 ASEAN METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 14 ASEAN INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 15 ASEAN MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 16 ASEAN NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 ASEAN HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 18 ASEAN HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 19 ASEAN HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 20 ASEAN HEALTH SCREENING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 21 INDIA HEALTH SCREENING MARKET, BY CITY, 2022-2031 (USD MILLION)
TABLE 22 INDIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 23 INDIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 24 INDIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 25 INDIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 26 INDIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 27 INDIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 28 INDIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 29 INDIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 30 INDIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 31 INDIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 32 INDIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 33 INDIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 34 INDIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 35 INDIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 36 INDIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 37 INDIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 38 INDIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 39 INDIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 40 INDIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 41 SINGAPORE HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)..
TABLE 42 SINGAPORE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 43 SINGAPORE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 44 SINGAPORE CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 45 SINGAPORE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 46 SINGAPORE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 47 SINGAPORE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 48 SINGAPORE OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 49 SINGAPORE HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 50 SINGAPORE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 51 SINGAPORE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 SINGAPORE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 SINGAPORE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 54 SINGAPORE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 55 SINGAPORE HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 56 SINGAPORE HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 57 SINGAPORE HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 58 SINGAPORE HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 59 SINGAPORE HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 60 THAILAND HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 61 THAILAND CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 62 THAILAND DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 63 THAILAND CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 64 THAILAND GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 65 THAILAND REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 66 THAILAND STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 67 THAILAND OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 68 THAILAND HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 69 THAILAND CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 70 THAILAND METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 71 THAILAND INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 72 THAILAND MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 THAILAND NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 THAILAND HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)..
TABLE 75 THAILAND HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 76 THAILAND HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 77 THAILAND HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 78 THAILAND HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 79 MALAYSIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 80 MALAYSIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 81 MALAYSIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 82 MALAYSIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 83 MALAYSIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 84 MALAYSIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 85 MALAYSIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 86 MALAYSIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 87 MALAYSIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 88 MALAYSIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 MALAYSIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 90 MALAYSIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 MALAYSIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 MALAYSIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 93 MALAYSIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)..
TABLE 94 MALAYSIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 95 MALAYSIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 96 MALAYSIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 97 MALAYSIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 98 INDONESIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)…
TABLE 99 INDONESIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 100 INDONESIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 101 INDONESIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 102 INDONESIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 103 INDONESIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 104 INDONESIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 105 INDONESIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 106 INDONESIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 107 INDONESIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 108 INDONESIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 INDONESIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 110 INDONESIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 111 INDONESIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 INDONESIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 113 INDONESIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 114 INDONESIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 115 INDONESIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 116 INDONESIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 117 PHILIPPINES HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 118 PHILIPPINES CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 119 PHILIPPINES DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 120 PHILIPPINES CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 121 PHILIPPINES GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 122 PHILIPPINES REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 123 PHILIPPINES STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 124 PHILIPPINES OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 125 PHILIPPINES HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 126 PHILIPPINES CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 127 PHILIPPINES METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 PHILIPPINES INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 129 PHILIPPINES MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 130 PHILIPPINES NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 PHILIPPINES HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 132 PHILIPPINES HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 133 PHILIPPINES HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 134 PHILIPPINES HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 135 PHILIPPINES HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 136 VIETNAM HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 137 VIETNAM CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 138 VIETNAM DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 139 VIETNAM CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 140 VIETNAM GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 141 VIETNAM REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 142 VIETNAM STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 143 VIETNAM OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 144 VIETNAM HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)..
TABLE 145 VIETNAM CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 VIETNAM METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 147 VIETNAM INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 148 VIETNAM MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 VIETNAM NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 VIETNAM HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 151 VIETNAM HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 152 VIETNAM HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 153 VIETNAM HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 154 VIETNAM HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 155 CAMBODIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)…
TABLE 156 CAMBODIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 157 CAMBODIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 158 CAMBODIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 159 CAMBODIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 160 CAMBODIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 161 CAMBODIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 162 CAMBODIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 163 CAMBODIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 164 CAMBODIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 165 CAMBODIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 166 CAMBODIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 167 CAMBODIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 168 CAMBODIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 CAMBODIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 170 CAMBODIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 171 CAMBODIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 172 CAMBODIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 173 CAMBODIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 174 BRUNEI HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 175 BRUNEI CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 176 BRUNEI DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 177 BRUNEI CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 178 BRUNEI GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 179 BRUNEI REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 180 BRUNEI STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 181 BRUNEI OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 182 BRUNEI HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 183 BRUNEI CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 184 BRUNEI METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 185 BRUNEI INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 186 BRUNEI MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 187 BRUNEI NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 188 BRUNEI HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 189 BRUNEI HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 190 BRUNEI HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 191 BRUNEI HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 192 BRUNEI HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 193 BURMA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 194 BURMA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 195 BURMA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 196 BURMA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 197 BURMA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 198 BURMA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 199 BURMA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 200 BURMA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 201 BURMA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 202 BURMA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 203 BURMA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 204 BURMA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 205 BURMA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 206 BURMA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 207 BURMA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 208 BURMA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 209 BURMA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 210 BURMA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 211 BURMA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 212 LAOS HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 213 LAOS CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 214 LAOS DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 215 LAOS CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 216 LAOS GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 217 LAOS REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 218 LAOS STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 219 LAOS OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 220 LAOS HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 221 LAOS CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 222 LAOS METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 223 LAOS INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 224 LAOS MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 225 LAOS NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 226 LAOS HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 227 LAOS HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 228 LAOS HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 229 LAOS HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 230 LAOS HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
List of Figure
FIGURE 1 ASEAN HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 2 ASEAN HEALTH SCREENING MARKET: DATA TRIANGULATION
FIGURE 3 ASEAN HEALTH SCREENING MARKET: DROC ANALYSIS
FIGURE 4 ASEAN HEALTH SCREENING MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 ASEAN HEALTH SCREENING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASEAN HEALTH SCREENING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASEAN HEALTH SCREENING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASEAN HEALTH SCREENING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASEAN HEALTH SCREENING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASEAN HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 11 SEVEN SEGMENTS COMPRISE THE ASEAN HEALTH SCREENING MARKET, BY TEST TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DEVELOPMENTS
FIGURE 14 RISING NUMBER OF CHRONIC DISEASES IS DRIVING THE GROWTH OF THE ASEAN HEALTH SCREENING MARKET FROM 2024 TO 2031
FIGURE 15 THE CHOLESTEROL TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASEAN HEALTH SCREENING MARKET IN 2024 AND 2031
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASEAN HEALTH SCREENING MARKET
FIGURE 17 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, 2023
FIGURE 18 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, 2024-2031 (USD MILLION)
FIGURE 19 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, CAGR (2024-2031)
FIGURE 20 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 21 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, 2023
FIGURE 22 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, 2024-2031 (USD MILLION)
FIGURE 23 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, CAGR (2024-2031)
FIGURE 24 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, LIFELINE CURVE
FIGURE 25 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, 2023
FIGURE 26 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, 2024-2031 (USD MILLION)
FIGURE 27 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, CAGR (2024-2031)
FIGURE 28 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, LIFELINE CURVE
FIGURE 29 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, 2023
FIGURE 30 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 31 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 32 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, 2023
FIGURE 34 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, 2024-2031 (USD MILLION)
FIGURE 35 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, CAGR (2024-2031)
FIGURE 36 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, LIFELINE CURVE
FIGURE 37 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, 2023
FIGURE 38 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, 2024-2031 (USD MILLION)
FIGURE 39 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, CAGR (2024-2031)
FIGURE 40 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 41 ASEAN HEALTH SCREENING MARKET: BY USER, 2023
FIGURE 42 ASEAN HEALTH SCREENING MARKET: BY USER, 2024-2031 (USD MILLION)
FIGURE 43 ASEAN HEALTH SCREENING MARKET: BY USER, CAGR (2024-2031)
FIGURE 44 ASEAN HEALTH SCREENING MARKET: BY USER, LIFELINE CURVE
FIGURE 45 ASEAN HEALTH SCREENING MARKET: SNAPSHOT, 2023
FIGURE 46 ASEAN MEDICAL SCREENING MARKET: COMPANY SHARE 2023 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
